Home
Subscription
January 2025 issue
BACK ISSUES
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2008 Issues
December 2008 Issue
Feature - Editorial Updates and Perspectives
Editor's Note
New therapeutic agents marketed in the United States in 2008
November 2008 Issue
Feature - The Health Care Pretenders Health Insurance Companies Should Stick to Providing Insurance and Not Attempt to be Health Care Providers
New Drug Review - Tetrabenazine (Xenazine - Ovation; Prestwick)
October 2008 Issue
Feature - January 1, 2010 Make This Date the Goal to Get Cigarettes Out of All Pharmacies!
New Drug Review - Difluprednate (Durezol - Sirion)
September 2008 Issue
Feature - North Dakota has it Right! Challenges to its Pharmacy Ownership Law must be Rejected!
APHA's Executive Search
New Drug Review - Sapropterin dihydrochloride (Kuvan - BioMarin)
August 2008 Issue
Feature - 2015 When the Shortage of Pharmacists
Becomes a Surplus! (Unless Major Changes Occur in the Practice of Pharmacy Very Soon)
New Drug Review - Alvimopan (Entereg - Adolor; GlaxoSmithKline)
July 2008 Issue
Feature - Concern for Patients or Protection of Profits? Legislation Regarding Generic Antiepileptic Drugs is Not Needed!
New Drug Review - Methylnaltrexone bromide (Relistor - Progenics; Wyeth)
June 2008 Issue
Feature - A Mail-Order Myth
New Drug Review - Sinecatechins (Veregen - Bradley)
May 2008 Issue
Feature - Consumer ReportsŐ Readers Rate Independent Pharmacies as the Best (but Some Opportunities are Being Missed)
Neat Mistakes
Memorial Day
New Drug Review - Certolizumab pegol (Cimzia - UCB)
April 2008 Issue
Feature - Health Insurance Threatens the Quality of Health Care!
New Drug Review - Desvenlafaxine succinate (Pristiq - Wyeth)
March 2008 Issue
Feature - The Chaos of Prescription Drug Benefit Programs
New Drug Review - Ciclesonide (Omnaris - Nycomed)
February 2008 Issue
Feature - Medication Errors (Again) - We Must be More Accountable!
New Drug Review - Etravirine (Intelence - Tibotec)
January 2008 Issue
Feature - HAPPY NEW YEAR! Resolutions for Our Profession
Postscript to the December Editorial
Editor's Note
New Drug Review - Nebivolol hydrochloride (Bystolic - Forest)
| |